Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1969 1
1970 1
1971 2
1972 4
1973 6
1974 1
1975 12
1976 10
1977 15
1978 4
1979 9
1980 16
1981 22
1982 12
1983 29
1984 23
1985 26
1986 22
1987 30
1988 38
1989 38
1990 48
1991 29
1992 43
1993 34
1994 47
1995 55
1996 45
1997 40
1998 55
1999 43
2000 54
2001 52
2002 63
2003 57
2004 51
2005 62
2006 56
2007 51
2008 69
2009 64
2010 58
2011 73
2012 81
2013 68
2014 54
2015 61
2016 46
2017 67
2018 70
2019 56
2020 58
Text availability
Article attribute
Article type
Publication date

Search Results

1,926 results
Results by year
Filters applied: . Clear all
Page 1
Anti-mitochondrial autoantibodies-milestone or byway to primary biliary cholangitis?
Tanaka A. Tanaka A. Ann Transl Med. 2017 Feb;5(3):50. doi: 10.21037/atm.2017.01.42. Ann Transl Med. 2017. PMID: 28251129 Free PMC article. No abstract available.
Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.
Hou Y, Liu M, Luo YB, Sun Y, Shao K, Dai T, Li W, Zhao Y, Yan C. Hou Y, et al. Neuromuscul Disord. 2019 Jan;29(1):5-13. doi: 10.1016/j.nmd.2018.11.004. Epub 2018 Nov 22. Neuromuscul Disord. 2019. PMID: 30579751 Free article.
Anti-mitochondrial antibodies, the hallmark of primary biliary cirrhosis, have been detected in many patients with idiopathic inflammatory myopathies and these anti-mitochondrial-antibody-associated idiopathic inflammatory myopathies frequently show un
Anti-mitochondrial antibodies, the hallmark of primary biliary cirrhosis, have been detected in many patients with idiopathic
Inflammatory myopathies associated with anti-mitochondrial antibodies.
Maeda MH, Tsuji S, Shimizu J. Maeda MH, et al. Brain. 2012 Jun;135(Pt 6):1767-77. doi: 10.1093/brain/aws106. Epub 2012 May 4. Brain. 2012. PMID: 22561642
Anti-mitochondrial antibodies, the characteristic markers of primary biliary cirrhosis, have been detected in most patients with this disease. ...The clinical and histopathological features of anti-mitochondrial antibody-positive patients were analysed
Anti-mitochondrial antibodies, the characteristic markers of primary biliary cirrhosis, have been detected in most patients wi
Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.
Albayda J, Khan A, Casciola-Rosen L, Corse AM, Paik JJ, Christopher-Stine L. Albayda J, et al. Semin Arthritis Rheum. 2018 Feb;47(4):552-556. doi: 10.1016/j.semarthrit.2017.06.004. Epub 2017 Jun 13. Semin Arthritis Rheum. 2018. PMID: 28893408 Free PMC article.
We sought to review all cases of anti-mitochondrial antibody (AMA) associated myositis in our cohort to describe the clinical features of this disease subset. ...We propose that anti-mitochondrial antibody status should be determined in patients with a …
We sought to review all cases of anti-mitochondrial antibody (AMA) associated myositis in our cohort to describe the clinical …
Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.
Tsuneyama K, Baba H, Morimoto Y, Tsunematsu T, Ogawa H. Tsuneyama K, et al. J Med Invest. 2017;64(1.2):7-13. doi: 10.2152/jmi.64.7. J Med Invest. 2017. PMID: 28373632 Free article. Review.
The serological hallmark of PBC is the presence of anti-mitochondrial autoantibodies (AMA). Several mechanisms have been proposed for immune-mediated bile duct damage in PBC, including the roles of T cells, B cells, other cell phenotypes, and AMA. ...
The serological hallmark of PBC is the presence of anti-mitochondrial autoantibodies (AMA). Several mechanisms have been propo …
Pathophysiology of primary biliary cholangitis.
Gulamhusein AF, Hirschfield GM. Gulamhusein AF, et al. Best Pract Res Clin Gastroenterol. 2018 Jun-Aug;34-35:17-25. doi: 10.1016/j.bpg.2018.05.012. Epub 2018 May 24. Best Pract Res Clin Gastroenterol. 2018. PMID: 30343706 Review.
Primary biliary cholangitis is a prototypical autoimmune disease characterized by an overwhelming female predominance, a distinct clinical phenotype, and disease specific anti-mitochondrial antibodies targeted against a well-defined auto-antigen. ...First, character …
Primary biliary cholangitis is a prototypical autoimmune disease characterized by an overwhelming female predominance, a distinct clinical p …
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies.
Calise SJ, Zheng B, Hasegawa T, Satoh M, Isailovic N, Ceribelli A, Andrade LEC, Boylan K, Cavazzana I, Fritzler MJ, de la Torre IG, Hiepe F, Kohl K, Selmi C, Shoenfeld Y, Tincani A, Chan EKL; IUIS Autoantibody Standardization Committee. Calise SJ, et al. Clin Chem Lab Med. 2018 Sep 25;56(10):1789-1798. doi: 10.1515/cclm-2017-1152. Clin Chem Lab Med. 2018. PMID: 29478040 No abstract available.
The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Terziroli Beretta-Piccoli B, et al. J Autoimmun. 2018 Dec;95:144-158. doi: 10.1016/j.jaut.2018.10.004. Epub 2018 Oct 23. J Autoimmun. 2018. PMID: 30366656 Review.
Anti-liver kidney microsomal antibody type 1 is the serological hallmark of type 2 AIH, often in association with anti-liver cytosol type 1 antibody. ...Anti-mitochondrial antibody is the hallmark of primary biliary cholangitis (PBC), being disease-spe
Anti-liver kidney microsomal antibody type 1 is the serological hallmark of type 2 AIH, often in association with anti-liver c
Vitiligo and autoantibodies: a systematic review and meta-analysis.
Liu CW, Huang YC. Liu CW, et al. J Dtsch Dermatol Ges. 2018 Jul;16(7):845-851. doi: 10.1111/ddg.13574. Epub 2018 Jul 4. J Dtsch Dermatol Ges. 2018. PMID: 29972626
The prevalence of anti-thyroperoxidase (ATPO) antibodies, anti-thyroglobulin (ATG) antibodies, antinuclear antibodies (ANA), anti-gastric parietal cell antibodies (AGPCA), anti-smooth muscle antibodies (ASMA), anti-mitochondrial antibodie …
The prevalence of anti-thyroperoxidase (ATPO) antibodies, anti-thyroglobulin (ATG) antibodies, antinuclear antibodies (ANA), …
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX.
Sotgia F, Ozsvari B, Fiorillo M, De Francesco EM, Bonuccelli G, Lisanti MP. Sotgia F, et al. Cell Cycle. 2018;17(17):2091-2100. doi: 10.1080/15384101.2018.1515551. Epub 2018 Sep 26. Cell Cycle. 2018. PMID: 30257595 Free PMC article. Review.
In the future, we envision that anti-mitochondrial therapy would ultimately be practiced as an add-on to more conventional therapy, largely for the prevention of tumor recurrence and cancer metastasis. ...Thus, we propose the term MITO-ONC-RX, to describe this an
In the future, we envision that anti-mitochondrial therapy would ultimately be practiced as an add-on to more conventional the …
1,926 results
Jump to page
Feedback